| abstract |
FIELD: medicine.SUBSTANCE: method for detecting diabetic fetopathy of the fetus is proposed, including determining the content of at least one marker of diabetic fetopathy of the fetus, selected from the group consisting of alpha-1-microglobulin / bikunin precursor (AMBP), apolipoprotein A-II, apolipoprotein B-100, apolipoprotein C-III, complement factor H, prothrombin, kininogen-1, alpha-1-acid glycoprotein, plasminogen, inter-alpha-trypsin inhibitor H1 heavy chain and vitronectin, in the analyte, determination of the total protein content in the analyte, assessment of the proportion of at least one marker diabetic fetopathy of the fetus from the total protein content in the analyte.EFFECT: invention improves accuracy of the analysis, as well as expanding the arsenal of existing methods of analysis in the diagnosis of diabetic fetopathy of the fetus.5 cl, 5 dwg, 3 ex |